- Home
- LITB vs ENLV Comparison
LITB vs ENLV Comparison
Compare LITB & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITB
- ENLV
- Stock Information
- Founded
- LITB 2007
- ENLV 2005
- Country
- LITB Singapore
- ENLV Israel
- Employees
- LITB N/A
- ENLV N/A
- Industry
- LITB Catalog/Specialty Distribution
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- LITB Consumer Discretionary
- ENLV Health Care
- Exchange
- LITB Nasdaq
- ENLV Nasdaq
- Market Cap
- LITB 32.2M
- ENLV 24.4M
- IPO Year
- LITB N/A
- ENLV 1995
- Fundamental
- Price
- LITB $1.14
- ENLV $1.06
- Analyst Decision
- LITB
- ENLV Strong Buy
- Analyst Count
- LITB 0
- ENLV 2
- Target Price
- LITB N/A
- ENLV $9.50
- AVG Volume (30 Days)
- LITB 17.1K
- ENLV 71.3K
- Earning Date
- LITB 03-24-2025
- ENLV 03-28-2025
- Dividend Yield
- LITB N/A
- ENLV N/A
- EPS Growth
- LITB N/A
- ENLV N/A
- EPS
- LITB N/A
- ENLV N/A
- Revenue
- LITB $333,093,000.00
- ENLV N/A
- Revenue This Year
- LITB N/A
- ENLV N/A
- Revenue Next Year
- LITB N/A
- ENLV N/A
- P/E Ratio
- LITB N/A
- ENLV N/A
- Revenue Growth
- LITB N/A
- ENLV N/A
- 52 Week Low
- LITB $1.00
- ENLV $0.81
- 52 Week High
- LITB $6.30
- ENLV $4.59
- Technical
- Relative Strength Index (RSI)
- LITB 40.94
- ENLV 36.10
- Support Level
- LITB $1.00
- ENLV $1.05
- Resistance Level
- LITB $1.25
- ENLV $1.21
- Average True Range (ATR)
- LITB 0.15
- ENLV 0.06
- MACD
- LITB 0.01
- ENLV -0.01
- Stochastic Oscillator
- LITB 51.61
- ENLV 38.10
About LITB LightInTheBox Holding Co. Ltd.
LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company is engaged in product sales which consisted of online retailing of consumer products. It also provides services which consisted of the provision of logistic services to e-commerce retailers and small businesses. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.